Sign in
4

Changes in Ownership

Eloxx Pharmaceuticals, Inc. Filed Acc 0001144204-14-069947

Options or other derivatives

  • Director acquired 36,968 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

RECTOR DAVID · Director

Table II: Derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2014-11-18 Grant or award : show line 1 in the form Common Stock Option (right to buy) +31,698 73,380 D
2014-11-18 Grant or award : show line 2 in the form Common Stock Option (right to buy) +5,270 $0.42 $2,213 78,650 D
Loading xslF345X03/form471636_20141120093332-.xml…